Genmab
Venture Capital
Genmab is an international biotechnology company specializing in differentiated antibody therapeutics for the treatment of cancer and other serious diseases.
Copenhagen, Denmark · 2+ investments
Biotech
Immunology
Oncology
- Headquarters
- Copenhagen, Denmark
- Founded
- 2000
- Website
- genmab.com
- Total Investments
- 2
- Last Investment
- Sep 2025
Investment Thesis
Genmab develops differentiated antibody therapeutics through innovation and strategic partnerships, focusing on cancer and serious diseases to improve patient outcomes.
Genmab is a Venture Capital firm based in Copenhagen, Denmark. It has made 2 investments in Biotech and Immunology.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.